|
|
 |
|
One Health News |
| |
|
| |
| Found 1196 Matching Results. View archived News Here. |
|
|
|
| Animal Clinic (USA) Promotes One Health on Website - Thursday, September 29, 2011 |
Animal Clinic (USA) Promotes One Health on Website
Bennett Porter III, DVM, owner of the Westgate Pet Clinic in Minneapolis, Minnesota (USA), posted a One Health promotional website News item on September 7, 2011. Dr. Porter is one of the early visionary private practice veterinarians to recognize the importance of appreciating and engaging the One Health concept.
Please see: http://www.wagsandwhiskers.com/aboutus/News.asp?keyID=68 |
|
| Contagion Movie was One Health Deficient...making it Unrealistic! - Review September 29, 2011 - Wednesday, September 28, 2011 |
Contagion Movie was One Health Deficient...making it Unrealistic!
What Contagion missed
By Laura H. Kahn, MD, MPH, MPP | 29 September 2011
“It's not often that Hollywood ventures into the realm of epidemics and public health, and when it does, the outcome is usually laughably out of touch with reality -- like Outbreak, the 1995 movie about a deadly Ebola-like virus that infected a city. ...”
Please read the entire review in Dr. Kahn’s Bulletin of the Atomic Scientists column:
http://thebulletin.org/web-edition/columnists/laura-h-kahn/what-contagion-missed |
|
| A provocative example of One Health Principles: Emergence of Antiviral Resistance Due to Unintended Exposure of an Animal Reservoir of Influenza to a Human Drug - Monday, September 26, 2011 |
A provocative example of One Health Principles: Emergence of Antiviral Resistance Due to Unintended Exposure of an Animal Reservoir of Influenza to a Human Drug
By Thomas P. Monath, MD - Kleiner Perkins Caufield & Byers and One Health Initiative team member
A recent study provides a provocative confluence of One Health issues. In an issue of PLoS One (2011;6(9): e24742) Järhult et al. report the induction of a mutation (H274Y) http://www.onehealthinitiative.com/publications/Oseltamivir%20resitance%20H1N1%20mallards%20PLoS%20ONE%2012Sep2011.pdf in the influenza A neuraminidase gene by infecting mallard ducks with influenza A/H1N1 virus and then exposing them to oseltamivir (Tamiflu) in a pool of water, the only source of water available to the animals. The H274Y mutation is responsible for resistance to oseltamivir, a neuraminidase inhibitor widely used for the prophylaxis and treatment of influenza A, and a mainstay antiviral drug stockpiled for emergency use in the event of an influenza pandemic. During the 2008-2009 flu season the H274Y mutation and resistance to the antiviral drug spread rapidly worldwide. As pointed out by the authors, the spread of H274Y resistant strains did not correlate with usage of oseltamivir in the human population, suggesting that other factors may have put selective pressure on the virus.
The concentration of oseltamivir in water fed to the mallards in the experiment that induced the resistance mutation was as low as 1ƒÝg/mL, but not at 80 ng/mL. Ducks were infected and exposed to drug in 10 generations of 5 days each, with new ducks being introduced every third day allowing transfer of virus to the new ducks for 2 days before the preceding generation was removed. Mutated virus was detected as early as 8 days (second generation).
What lessons derive from this experiment? It is clear that resistance to oseltamivir can be induced rapidly in ducks after experimental exposure to water containing low concentrations of drug. Ducks are a primary reservoir of influenza A viruses, and a source of introduction of virus to the human population. They also move long distances, both by local and long-distance migrations, and by being moved in human conveyances to market. The central questions, not answered by this study, are whether natural exposure of wild and domesticated ducks (and other aquatic birds) occurs to oseltamivir in the environment, how widespread such environmental contamination is, and what concentrations are present.
Oseltamivir is actually a prodrug since the active form is not readily bioavailable from the gastrointestinal tract. The prodrug (osltamivir phosphate) is metabolized to the active form (oseltamivir carboxylate). The latter is excreted in the urine unchanged, and thus could find its way from human patients to sewage plants and the environment. Multiple studies cited in the paper have demonstrated that oseltamivir carboxylate is stable in sewage and it has been detected in waste water, rivers, and sewage effluent. However, levels reported from samples taken in nature ranged from 58-293 ng/mL, below the 1 ƒÝg/mL that induced resistance experimentally. However, the high end of this range was not tested in the experiments performed, and environmental levels could reach higher concentrations in focal areas or with high usage of drug in the human population during a pandemic.
If oseltamivir contamination of aquatic environments—an unintended treatment of the zoonotic reservoir host of influenza A viruses—are factors in the emergence and spread of antiviral resistance, this would appear to be a difficult problem to control. It would also be an unprecedented and unique mechanism in disease emergence. The closest analogy is the use of antibiotics in animal feed in the evolution of antibiotic resistant bacteria, but for oseltamivir the exposure is unintended. The implications for One Health are clear and impressive, involving a human drug, environmental contamination, and the emergence of a zoonotic infection with a new virulence factor.
Note: Dr. Monath, an eminent medical virologist and physician, is a partner in the Pandemic and Biodefense Fund, Kleiner Perkins Caufield & Byers, and also Adjunct Professor, Harvard School of Public Health. Between 1992 and 2006, he was Chief Scientific Officer and Executive Director of Acambis (a publicly traded biopharmaceutical company) where he directed R & D on vaccines against dengue, Japanese encephalitis, West Nile, yellow fever, Clostridium difficile, as well as smallpox vaccines for defense against bioterrorism. |
|
| The Flu Contagion - One Health Initiative website - Friday, September 23, 2011 |
The Flu Contagion
Prepared and submitted to the One Health Initiative website September 19, 2011 by:
Clint McDaniel MPH, CPH
Virology Laboratory Technician
Global Pathogens Laboratory http://gpl.phhp.ufl.edu
Emerging Pathogens Institute
Department of Environmental and Global Health
College of Public Health and Health Profession
University of Florida, Gainesville, FL (USA)
While the current Hollywood thriller Contagion is fictional, the idea of a novel outbreak of life and death proportion is very real. They have happened before. One of the most famous pandemics was the “Spanish flu” of 1918 that spread across the globe killing 50-100 million people – or 3% to 6% of the entire global population. With the emergence of the 2009 pandemic influenza virus, we are once again reminded of the potential of the influenza virus spreading across the Earth with surprising ease.
Warning signs continue to emerge with three notable events in the past month alone. A recent death in an otherwise healthy 80-year-old female has “surprised” health officials, serving as a reminder that the 2009 pandemic virus is still circulating and able to cause a significant morbidity. In a similar warning, the United Nations’s (UN) Food and Agriculture Organization (FAO) encouraged increased influenza surveillance due to “a possible major resurgence of bird flu” from a mutant strain of the H5N1 virus emerging throughout Asia. These warnings are further compounded by the recent off season detection of novel influenza viruses among sick U.S. children. At last count four children have been infected with hybrid or reassortant virus that are a combination of the 2009 pandemic human virus and North American pig viruses. One of the four children had no contact with pigs suggesting that such novel viruses are circulating in people. These modifications to the 2009 pandemic virus have public health officials concerned.
Influenza surveillance in U.S. pigs is very limited and like in the film Contagion, such a novel virus could emerge from pig populations and find us totally unprepared.
Reference:
The Centers for Disease Control and Prevention. Swine-Origin Influenza A (H3N2) Virus Infection in Two Children --- Indiana and Pennsylvania, July--August 2011. Morbidity and mortality weekly report. 2011;60 (September 9):1213-5. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21900876.
|
|
| One Health potential: Promising Animal model for Human Hepatitis C virus - September 21, 2011 - Wednesday, September 21, 2011 |
One Health potential: Promising Animal model for Human Hepatitis C virus
Canine [dog] Hepacivirus
A report by Kapoor et al. (2011) recently published in Proceedings of the National Academy of Sciences (PNAS) journal describes a canine homolog of hepatitis C virus (HCV), dubbed canine hepacivirus (CHV), which is closely related to HCV.[1] CHV is a respiratory illness in dogs, with low virus titers found in the liver. The authors were unsure whether CHV is hepatotropic (ability of the virus to replicate in the liver). They estimate the 2 viruses diverged in the past 500-1000 years, after canine domestication. The authors suggest HCV emerged from human infections with CHV. This discovery provides a promising animal model in which to study the pathogenesis and treatment of HCV.
1. Kapoor, A., et al., Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A, 2011. 108(28): p. 11608-13.
Note: PNAS is the official journal of the United States National Academy of Sciences (NAS).
Provided by:
Whitney Baker Krueger, PhDc, MPH
Global Pathogens Laboratory http://gpl.phhp.ufl.edu, Emerging Pathogens Institute, Department of Environmental and Global Health, College of Public Health and Health Profession, University of Florida, Gainesville, FL (USA). |
|
| National study on the prioritization of zoonotic diseases in the United States - September 19, 2011 - Monday, September 19, 2011 |
National study on the prioritization of zoonotic diseases in the United States
September 19, 2011—The following message is being circulated on behalf of the Centre for Public Health and Zoonoses (CPHAZ) Research Team at the Ontario Veterinary College, University of Guelph, ON, Canada by the One Health Initiative Team. We encourage you to consider participation and strongly support the efforts of CPHAZ:
“You are cordially invited to participate in a national web-survey on the prioritization of zoonotic diseases in the United States.
This survey has been developed by researchers at the Centre for Public Health and Zoonoses and will identify the relative importance of key characteristics of zoonoses that can be used to prioritize disease for their control and prevention in the United States like we did in Canada. The survey responses will be used to develop a point-scoring system to derive a recommended list of zoonoses for prioritization in the United States. You will be presented with 16 scenarios consisting of five disease profiles each. For each scenario, you will be asked to choose one for prioritization.
You do not need to have any prior knowledge of zoonoses or experience in disease prioritization to participate in this study. All, who reside in the United States are encouraged to participate.
No identifiable information will be collected during the survey and your response will remain anonymous.
The survey will take approximately 20 to 25 minutes to complete and can be accessed through the following link:
http://www2.ovc.uoguelph.ca/survey/us/en/US_profenglishlogin.html
The survey is also available in Spanish through this link:
http://www2.ovc.uoguelph.ca/survey/us/es/US_profspanishlogin.html
We would like to thank the One Health Initiative for their help in distributing this survey.
If you have any questions or concerns, please contact Dr. Victoria Ng at vng03@uoguelph.ca.
Thank you,
Centre for Public Health and Zoonoses (CPHAZ) Research Team.” |
|
| Catalog of One Health Activities and Programs (USA) - September 2011 - Saturday, September 17, 2011 |
Important New - September 2011
Catalog of One Health Activities and Programs (USA)
Please see http://www.onehealthinitiative.com/publications/One%20Health%20Catalog.pdf
Provided by:
Will Hueston, DVM, PhD
Executive Director, Global Initiative for Food Systems Leadership
Professor, College of Veterinary Medicine and
Adjunct Professor, School of Public Health
University of Minnesota
St. Paul, MN (USA)
Tel: 612-625-5900
Fax: 612-624-4906
Email: huest001@umn.edu
Website: www.foodsystemsleadership.org |
|
| Reminder...Symposium: One World, One Health, One Medicine – IDSA Annual Meeting Boston, MA (USA) - October 21, 2011 - Thursday, September 15, 2011 |
Reminder...Symposium: One World, One Health, One Medicine – IDSA Annual Meeting Boston, MA (USA)
Friday, October 21, 2011: 2:15 PM-4:15 PM, Room 153 ABC
http://idsa.confex.com/idsa/2011/webprogram/Session2361.html
Learning Objectives:
At the conclusion of this session, participants will be able to:
· describe the mission of the One Health initiative to unite physicians, veterinarians, and other health care professionals to improve human health
· recognize the importance of the interface of humans, animals, and the environment in development of infectious diseases
· summarize how global hotspots for emerging and reemerging infectious diseases are identified and monitored
· review how the interactions of humans, domestic animals, and wildlife contribute to emerging infectious diseases
· propose how emergent zoonoses can be identified and prevented
Target Audience: Vaccinologists, Scientists, Researchers, Public Health Practitioners, Pharmacists, Nurses, Microbiologists, Lab Personnel, Investigators, Infectious Diseases Physicians, Infectious Diseases Pediatricians, Infection Preventionists, Hospital Epidemiologists, Hospital Administrators, HIV Clinicians, Health Care Workers, Fellows-in-Training, Epidemiologists, Clinicians, Academicians
Tracks: Global ID, Investigative ID, Pediatric ID, Adult ID
Moderators: James Hughes, MD, FIDSA, Emory University and Lonnie King, DVM, College of Veterinary Medicine at Ohio State University
Presentations:
|
|
| “One Health” Theme for General Medical Library Association Meeting 2013 in Boston, MA (USA) - May 3-8, 2013 - Monday, September 12, 2011 |
Important One Health Announcement
“One Health” Theme for General Medical Library Association Meeting 2013 in Boston, MA (USA)
“The 2013 Medical Library Association Boston, MA (USA) http://mlanet.org/ May 3-8 meeting will incorporate the Medical Library Association, the 11th International Congress on Medical Librarianship (ICML), the 7th International Conference of Animal Health Information Specialists (ICAHIS), and the 6th International Clinical Librarian Conference (ICLC).
The general meeting theme for 2013 is “One Health: Information in an Interdependent World” and is meant to encompass human and animal health, public health, environmental health, climate change, food safety/production, and international health policy. The NPC is also working with 4 general meeting topics around which we are considering plenary speakers in the overall context of “One Health”: Trustworthy and Authoritative Publicly Available Information; New Methods of Publishing; Global Data Sharing to Advance Science; Environmental Aspects of Global Health.”
Note: The Medical Library Association (MLA) is a nonprofit, educational organization with more than 4,000 health sciences information professional members and partners worldwide. MLA provides lifelong educational opportunities, supports a knowledgebase of health information research, and works with a global network of partners to promote the importance of quality information for improved health to the health care community and the public.
Information graciously provided by longstanding and highly valued One Health supporter:
Diane A. Fagen, Librarian / Copyright & Permissions / Electronic Access / Archives
American Veterinary Medical Association
1931 N Meacham Rd
Schaumburg IL 60173-4360
p: 800-248-2862 ext 6770
f: 847-925-9329
e: dfagen@avma.org
|
|
| Panel Discussion NOTICE One Health: The Convergence of Human, Animal and Environmental Health - September 15, 2011 - Sunday, September 11, 2011 |
Panel Discussion NOTICE One Health: The Convergence of Human, Animal and Environmental Health
September 15, 2011, 9:00 a.m. - Location: MassDiGI at Becker College, 80 William Street, Worcester, MA (USA)
The One Health Commission is a call to action for collaboration and cooperation among health science professions, academic institutions, governmental agencies, non-governmental organizations, and industries towards improved assessment, treatment, and prevention of cross-species disease transmission and mutually prevalent, but non-transmitted, human and animal diseases and medical conditions.
Becker College President Robert Johnson chose to include this panel, to raise awareness of this pressing topic, as part of Inauguration Week events.
Honorary Chair and Moderator John Sullivan, M.D., vice provost of research, professor of Molecular Medicine and Pediatrics, University of Massachusetts Medical School
Margaret Delano, DVM, Professor of Veterinary Science, Becker College
James Fox, DVM, Professor and Director, Division of Comparative Medicine at the Massachusetts Institute of Technology
Deborah Kochevar, DVM, Dean and Henry and Lois Foster Professor, Tufts University Cummings School of Veterinary Medicine
Roger Mahr, DVM, CEO, One Health Commission
Leonard Marcus, VMD, MD
Jerald Silverman, DVM, Professor, University of Massachusetts Medical School
Information provided September 13, 2011 by:
Contact: Sandy Lashin-Curewitz - Email: Sandy.Curewitz@Becker.edu |
|
|
|
|
|
|